Avricore Health Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was CAD 0.572228 million compared to CAD 0.075104 million a year ago. Net loss was CAD 0.180398 million compared to CAD 0.439311 million a year ago.
For the nine months, sales was CAD 0.791139 million compared to CAD 0.087618 million a year ago. Net loss was CAD 0.573439 million compared to CAD 1.5 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.02 a year ago.